1,3-Dihydro-4-methyl-5-(4-methylthiobenzoyl)-2H-imidazol-2-one
CAS: 77671-31-9
Ref. 3D-FD137551
| 1mg | To inquire | ||
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Wednesday 8 Jan 2025
Product Information
Name:
1,3-Dihydro-4-methyl-5-(4-methylthiobenzoyl)-2H-imidazol-2-one
Synonyms:
- 1,3-Dihydro-4-methyl-5-[4-(methylthio)benzoyl]-2H-imidazol-2-one
- 2H-Imidazol-2-one, 1,3-dihydro-4-methyl-5-(4-(methylthio)benzoyl)-
- 4-Methyl-5-[4-(methylsulfanyl)benzoyl]-1,3-dihydro-2H-imidazol-2-one
- 77671-31-9
- Fenoximone
- Mdl 17043
- Perfan
- Perfane
- Rmi 17043
Description:
1,3-Dihydro-4-methyl-5-(4-methylthiobenzoyl)-2H-imidazol-2-one is a compound that has been used in the treatment of autoimmune diseases. It is a drug that is used to treat heart disease, such as congestive heart failure, and has also been shown to be effective in treating infectious diseases. This drug is administered orally and inhibits enzymes such as phosphodiesterase III and acetylcholine esterase. It is also approved for the treatment of bowel disease.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
248.3 g/mol
Formula:
C12H12N2O2S
Purity:
Min. 95%
InChI:
InChI=1S/C12H12N2O2S/c1-7-10(14-12(16)13-7)11(15)8-3-5-9(17-2)6-4-8/h3-6H,1-2H3,(H2,13,14,16)
InChI key:
InChIKey=ZJKNESGOIKRXQY-UHFFFAOYSA-N
SMILES:
CSc1ccc(C(=O)c2[nH]c(=O)[nH]c2C)cc1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 3D-FD137551 1,3-Dihydro-4-methyl-5-(4-methylthiobenzoyl)-2H-imidazol-2-one
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
